Establishment Labs Holdings Inc.

ESTA's 19.54% short interest is extraordinarily high for a $2.1B market-cap company, suggesting substantial bearish conviction. The stock trades 60.3 RSI—approaching overbought but not extreme—while sitting below its 52-week high, indicating recent weakness despite surgical-device sector tailwinds. The absence of a P/E ratio signals either unprofitability or data gaps, which compounds uncertainty around valuation. This combination of elevated shorts, middling momentum, and unclear earnings power creates classic squeeze vulnerability if sentiment shifts, though the significant short position could also reflect legitimate concerns about the company's profitability trajectory or competitive positioning within orthopedic devices.